Elizabeth Plaza - Pharma-Bio Serv Chairman

PBSV Stock

USD 0.50 0.02 4.17%

Chairman

Ms. Elizabeth Plaza is the Chairman of the Board of the Company. Also, Ms. Plaza assumed the role of Senior Strategic Consultant of the Company on January 1, 2013. Ms. Plaza served as our president and chief executive officer from January 2006 to December 2012, and as our principal executive officer from January 1, 2014 to December 31, 2014 since 2015.

Age	59
Tenure	9 years
Phone	787 278 2709
Web	https://www.pharmabioserv.com

Plaza holds a B.S. in Pharmaceutical Sciences, magna cum laude, from the School of Pharmacy of the University of Puerto Rico. She was a 40 under 40 Caribbean Business Award recipient in 2002, the 2003 recipient of Ernst & Young’s Entrepreneur of the Year Award in Health Science, one of the 2003 recipients of the Puerto Rico Powerful Business Women Award, elected as Puerto Rico Manufacturers Association 2004 Executive of the Year, and Puerto Rico 2008 Executive of the Year. She is member of the US Department of Commerce National Advisory Council on Minority Business Enterprise and is also member of the Puerto Rico Manufacturer Association Board of Directors.

Pharma-Bio Serv Management Efficiency

The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma-Bio Serv's management efficiency ratios could be used to measure how well Pharma-Bio Serv manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Pharma-Bio Serv to Peers

Predict price of Pharma-Bio Serv

Pharma Bio Serv currently holds 520.77 K in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Pharma Bio Serv has a current ratio of 8.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Pharma-Bio Serv until it has trouble settling it off, either with new capital or with free cash flow. So, Pharma-Bio Serv's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharma Bio Serv sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharma-Bio to invest in growth at high rates of return. When we think about Pharma-Bio Serv's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 3 records			CHAIRMAN Age
	MD MPH	Mineralys Therapeutics, Common	47
	Mark Emalfarb	Dyadic International	68
	Eric Weisblum	Silo Pharma	54

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people. Pharma Bio Serv [PBSV] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

	Return On Equity	0.0568
	Return On Asset	0.033

Pharma Bio Serv Leadership Team

Elected by the shareholders, the Pharma-Bio Serv's board of directors comprises two types of representatives: Pharma-Bio Serv inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma-Bio. The board's role is to monitor Pharma-Bio Serv's management team and ensure that shareholders' interests are well served. Pharma-Bio Serv's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma-Bio Serv's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Pedro Lasanta, CFO, VP of Fin. and Admin. and Secretary
	Victor Sanchez, CEO and President and President of European Operations
	Elizabeth Plaza, Founder, Chairman, Sr. Strategic Consultant and Member of Nominating Committee
	Miriam MBA, HR Mang

Pharma-Bio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Pharma-Bio Serv a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	0.0568
	Return On Asset	0.033
	Profit Margin	0.05 %
	Operating Margin	0.06 %
	Current Valuation	4.87 M
	Shares Outstanding	22.95 M
	Shares Owned By Insiders	64.53 %
	Price To Earning	10.00 X
	Price To Book	1.15 X
	Price To Sales	0.90 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pharma-Bio OTC Stock Analysis

When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC